Physician profile
Robert E Deck
NPI 1386655967
$993.76
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.16 · 2020: $221 · 2021: $545 · 2022: $204.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $418.81 | 2019-2022 | |
| Pfizer INC. | $107.63 | 2020-2022 | |
| Amgen INC. | $57.20 | 2021-2022 | |
| Avion Pharmaceuticals | $56.34 | 2020-2022 | |
| Biom'Up France Sas | $42.80 | 2021 | |
| Scynexis, INC. | $40.63 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $38.12 | 2020-2022 | |
| Exeltis, USA INC. | $35.56 | 2021 | |
| Minerva Surgical, INC | $25.61 | 2020-2021 | |
| Therapeuticsmd, INC. | $25.16 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $24.23 | 2020-2021 | |
| Sage Therapeutics, LLC | $16.86 | 2020 | |
| Mayne Pharma Commercial LLC | $15.89 | 2022 | |
| Millicent US INC | $15.31 | 2020 | |
| Evofem Biosciences, INC. | $15.06 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $14.98 | 2021 | |
| Hologic Sales and Service, LLC | $14.70 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.49 | 2022 | |
| Merck Sharp & Dohme LLC | $14.38 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Deck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.